Trends in clinical features, postoperative outcomes, and long-term survival for gastric cancer: a Western experience with 1,278 patients over 30 years

World Journal of Surgical Oncology

Giovanni Battista Doglietto²  Guido Costamagna¹  Claudio Fiorillo²  Antonio Pio Tortorelli²  Sergio Alfieri²  Fausto Rosa² 

[1] Department of Digestive Endoscopy, Catholic University, “A. Gemelli” Hospital, Rome, Italy;Department of Digestive Surgery, Catholic University, “A. Gemelli” Hospital, Largo A. Gemelli, 8, Rome 00168, Italy

关键词: Long-term survival;    Surgery;    Gastric cancer;   

Others  :  1148669
DOI  :  10.1186/1477-7819-12-217

 received in 2014-03-21, accepted in 2014-07-04,  发布年份 2014

【 摘 要 】

Background

The aim of the present study was to identify temporal trends in long-term survival and postoperative outcomes and to analyze prognostic factors influencing the prognosis of patients with gastric cancer (GC) treated in a 30-year interval in a tertiary referral Western institution.

Methods

Between January 1980 and December 2010, 1,278 patients who were diagnosed with GC at the Digestive Surgery Department, Catholic University of Rome, Italy, were identified. Among them, 936 patients underwent surgical resection and were included in the analysis.

Results

Over time there was a significant improvement in postoperative outcomes. Morbidity and mortality rates decreased to 19.4% and 1.6%, respectively, in the last decade. By contrast, the multivisceral resection rate steadily increased from 12.7% to 29.6%. The overall five-year survival rate steadily increased over time, reaching 51% in the last decade, and 64.5% for R0 resections. Multivariate analysis showed a higher probability of overall survival for early stages (I and II), extended lymphadenectomy, and R0 resections.

Conclusions

Over three decades there was a significant improvement in perioperative and postoperative care and a steady increase in overall survival.

【 授权许可】

   
2014 Rosa et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: l: GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC Cancer- Base No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from http://globocan.iarc.fr webcite
• [2]Brown LM, Devesa SS: Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am 2002, 11:235-256.
• [3]Marrelli D, Roviello F, de Manzoni G, Morgagni P, Di Leo A, Saragoni L, De Stefano A, Folli S, Cordiano C, Pinto E, Italian Research Group for Gastric Cancer: Different patterns of recurrence in gastric cancer depending on Lauren’s histological type: longitudinal study. World J Surg 2002, 26:1160-1165.
• [4]Kubota H, Kotoh T, Masunaga R, Dhar DK, Shibakita M, Tachibana M, Kohno H, Nagasue N: Impact of screening survey of gastric cancer on clinicopathological features and survival: retrospective study at a single institution. Surgery 2000, 128:41-47.
• [5]Kim YS, Park HA, Kim BS, Yook JH, Lee MS: Efficacy of screening for gastric cancer in a Korean adult population: a case-control study. J Korean Med Sci 2000, 15:510-515.
• [6]Borch K, Jonsson B, Tarpila E, Franzén T, Berglund J, Kullman E, Franzén L: Changing pattern of histological type, location, stage and outcome of surgical treatment of gastric carcinoma. Br J Surg 2000, 87:618-626.
• [7]Machara Y, Kakeji Y, Oda S, Takahashi I, Akazawa K, Sugimachi K: Time trends of surgical treatment and the prognosis for Japanese patients with gastric cancer. Br J Cancer 2000, 83:986-991.
• [8]Lauren P: The two histological main types of gastric cancer carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 1965, 64:31-49.
• [9]Borrmann R: Geschwulste des Magens und Duodenums. In Handbuch der Speziellen Pathologischen Anatomie und Histologie, Volume 4. Edited by Henke F, Lubarsch O. Berlin, Germany: J Springer; 1926:812-1054.
• [10]Sobin LH, Gospodarowicz MK, Wittekind C: International Union Against Cancer (UICC) TNM Classification of Malignant Tumors. 7th edition. New York: Wiley-Liss; 2010.
• [11]Japanese Gastric Cancer Association: Japanese classification of gastric carcinoma: 2nd English edition. Gastric Cancer 1998, 1(1):10-24.
• [12]Siewert JR, Stein HJ: Classification of carcinoma of the oesophagogastric junction. Br J Surg 1998, 85:1457-1459.
• [13]Pacelli F, Papa V, Rosa F, Tortorelli AP, Sanchez AM, Covino M, Bossola M, Doglietto GB: Four hundred consecutive total gastrectomies for gastric cancer: a single-institution experience. Arch Surg 2008, 143:769-775.
• [14]Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ, MAGIC Trial Participants: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl JMed 2006, 355:11-20.
• [15]Brenner H, Rothenbacher D, Arndt V: Epidemiology of stomach cancer. Methods Mol Biol 2009, 472:467-477.
• [16]Hanna GB, Boshier PR, Knaggs A, Goldin R, Sasako M: Improving outcomes after gastroesophageal cancer resection. Can Japanese results be reproduced in Western Centers? Arch Surg 2012, 147:738-745.
• [17]Cunningham SC, Kamangar F, Kim MP, Hammoud S, Haque R, Maitra A, Montgomery E, Heitmiller RE, Choti MA, Lillemoe KD, Cameron JL, Yeo CJ, Schulick RD: Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution. J Gastrointest Surg 2005, 9:718-725.
• [18]Marrelli D, Pedrazzani C, Morgagni P, de Manzoni G, Pacelli F, Coniglio A, Marchet A, Saragoni L, Giacopuzzi S, Roviello F: Changing clinical and pathological features of gastric cancer over time. Br J Surg 2011, 98:1273-1283.
• [19]Karpeh MS, Leon L, Klimstra D, Brennan MF: Lymph node staging in gastric cancer: is location more important than number? An analysis of 1038 patients. Ann Surg 2000, 232:362-371.
• [20]Inoue K, Nkane Y, Michiura T, Nakai K, Sato M, Okumura S, Yamamichi K, Okamura S, Imabayashi N: Trends in long-term survival following surgery for gastric cancer: a single institution experience. Oncol Rep 2004, 11:459-464.
• [21]Jähne J, Piso P, Meyer HJ: 1114 total gastrectomies in the surgical treatment of primary gastric adenocarcinoma: a 30-year single institution experience. Hepatogastroenterology 2001, 48:1222-1226.
• [22]Doglietto GB, Pacelli F, Caprino P, Bossola M, Di Stasi C: Pancreas-preserving total gastrectomy for gastric cancer. Arch Surg 2000, 135(1):89-94.
• [23]Pacelli F, Bossola M, Rosa F, Tortorelli AP, Papa V, Doglietto GB: Is malnutrition still a risk factor of postoperative complications in gastric cancer surgery? Clin Nutr 2008, 27:398-407.
• [24]Rosa F, Bossola M, Pacelli F, Alfieri S, Doglietto GB: Malnutrition and postoperative complications in abdominal surgery. Ann Surg 2011, 254:666-667.
• [25]Kim JP, Lee JH, Kim SJ, Yu HJ, Yang HK: Clinicopathologic characteristics and prognostic factors in 10783 patients with gastric cancer. Gastric Cancer 1998, 1:125-133.
• [26]Hundahl SA, Phillips JL, Menck HR: The National Cancer Data Base Report on poor survival of US gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the ‘different disease’ hypothesis. Cancer 2000, 88:921-932.
• [27]Smith DD, Schwarz RR, Schwarz RE: Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol 2005, 23:7114-7124.
• [28]Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ: Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 2010, 11:439-449.
• [29]Akoh JA, Macintyre IM: Improving survival in gastric cancer: review of 5-year survival rates in English language publications from 1970. Br J Surg 1992, 79:293-299.
• [30]Memon MA, Subramanya MS, Khan S, Hossain MB, Osland E, Memon B: Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma. Ann Surg 2011, 253(5):900-911.
• [31]Sasako M: Principles of surgical treatment for curable gastric cancer. J Clin Oncol 2003, 21(23):274s-275s.
• [32]Sano T, Sasako M, Yamamoto S, Nashimoto A, Kurita A, Hiratsuka M, Tsujinaka T, Kinoshita T, Arai K, Yamamura Y, Okajima K: Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy: Japan Clinical Oncology Group Study 9501. J Clin Oncol 2004, 22(14):2767-2773.
• [33]Siewert JR, Kestlmeier R, Busch R, Böttcher K, Roder JD, Müller J, Fellbaum C, Höfler H: Benefit of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. Br J Surg 1996, 83(8):1144-1147.
• [34]Pacelli F, Doglietto GB, Bellantone R, Alfieri S, Sgadari A, Crucitti F: Extensive versus limited lymph node dissection for gastric cancer: a comparative study of 320 patients. Br J Surg 1993, 80(9):1153-1156.
• [35]Degiuli M, Sasako M, Calgaro M, Garino M, Rebecchi F, Mineccia M, Scaglione D, Andreone D, Ponti A, Calvo F, Italian Gastric Cancer Study Group: Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomized surgical trial. Eur J Surg Oncol 2004, 30(3):303-308.
• [36]Edwards P, Blackshaw JR, Lewis WG, Barry JD, Allison MC, Jones DR: Prospective comparison of D1 vs modified D2 gastrectomy for carcinoma. Br J Cancer 2004, 90(10):1888-1892.
• [37]Rosa F, Tortorelli AP, Alfieri S, Doglietto GB: Lymph node ratio for gastric cancer: useful instrument or just an expedient to retrieve fewer lymph nodes? Ann Surg 2014, 259:e65.
• [38]Soreide JA, van Heerden JA, Burgart LJ, Donohue JH, Sarr MG, Ilstrup DM: Surgical aspects of patients with adenocarcinoma of the stomach operated on for cure. Arch Surg 1996, 131:481-486. discussion 486-488
• [39]Sanchez-Bueno F, Garcia-Marcilla JA, Perez-Flores D, Perez-Abad JM, Vicente R, Aranda F, Ramirez P, Parrilla P: Prognostic factors in a series of 297 patients with gastric adenocarcinoma undergoing surgical resection. Br J Surg 1998, 85:255-260.
• [40]Piso P, Werner U, Lang H, Mirena P, Klempnauer J: Proximal versus distal gastric carcinoma-what are the differences? Ann Surg Oncol 2000, 7:520-525.
• [41]Pacelli F, Papa V, Caprino P, Sgadari A, Bossola M, Doglietto GB: Proximal compared with distal gastric cancer: multivariate analysis of prognostic factors. Am Surg 2001, 67:697-703.
• [42]Pacelli F, Cusumano G, Rosa F, Marrelli D, Di Cosmo M, Cipollari C, Marchet A, Scaringi S, Rausei S, di Leo A, Roviello F, de Manzoni G, Nitti D, Tonelli F, Doglietto GB: Multivisceral Resection for Locally Advanced Gastric Cancer: an Italian Multicenter Observational Study (On behalf of the Italian Research Group for Gastric Cancer – IRGGC). JAMA Surg 2013, 148:353-360.
• [43]Catalano V, Labianca G, Beretta G, Gatta G, de Braud F, Van Cutsem E: Gastric cancer. Crit Rev Oncol Hematol 2009, 71:127-164.